Serato, Jave Akiro A.

HRN: 27-51-85  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
AMPICILLIN 500MG (VIAL)
08/08/2025
08/15/2025
IVT
114mg
Q12
T/C Neonatal Sepsis
Remove - Pending Acceptance
08/08/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/08/2025
08/14/2025
IVT
23mg
Q24
T/C Neonatal Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: